| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.31▼ | 4.26▲ | 4.25▲ | 4.27▲ | 4.22▲ |
| MA10 | 4.31▼ | 4.22▲ | 4.22▲ | 4.26▲ | 4.72▼ |
| MA20 | 4.27▲ | 4.20▲ | 4.21▲ | 4.23▲ | 4.92▼ |
| MA50 | 4.22▲ | 4.22▲ | 4.27▲ | 4.79▼ | 4.70▼ |
| MA100 | 4.19▲ | 4.27▲ | 4.24▲ | 4.89▼ | 3.94▲ |
| MA200 | 4.22▲ | 4.23▲ | 4.44▼ | 4.95▼ | 3.76▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | 0.019▲ | 0.017▲ | 0.041▲ | -0.143▼ |
| RSI | 60.455▲ | 60.307▲ | 55.710▲ | 45.553▼ | 42.604▼ |
| STOCH | 69.192 | 85.592▲ | 63.472 | 58.470 | 13.576▼ |
| WILL %R | -41.667 | -20.833▲ | -20.833▲ | -36.036 | -81.218▼ |
| CCI | 45.106 | 167.365▲ | 170.639▲ | 4.030 | -97.013 |
|
Tuesday, November 10, 2026 05:30 AM
Atea Pharmaceuticals (NASDAQ:AVIR) is targeting a mid-2027 U.S. application for its hepatitis C treatment, pending results from a second late-stage trial, and has secured a credit facility of up to ...
|
|
Monday, November 09, 2026 01:05 PM
Phase 3 C-BEYOND Trial Achieved Primary and Secondary Endpoints, Reinforcing Potential Best-in-Class Profile of BEM/RZR for Treatment of Hepatitis C Virus (HCV) Infection Phase 3 C-FORWARD Trial for H ...
|
|
Tuesday, September 29, 2026 07:32 AM
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Aviation and defense services provider AAR CORP (NYSE ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/11/26 | 4.14 | 4.355 | 4.11 | 4.30 | 254,323 |
| 12/11/26 | 4.17 | 4.29 | 4.09 | 4.21 | 244,197 |
| 11/11/26 | 4.22 | 4.34 | 4.04 | 4.22 | 320,528 |
| 10/11/26 | 4.40 | 4.44 | 4.16 | 4.20 | 301,493 |
| 09/11/26 | 4.35 | 4.48 | 4.315 | 4.41 | 244,167 |
| 06/11/26 | 4.21 | 4.35 | 4.12 | 4.31 | 199,472 |
| 05/11/26 | 4.48 | 4.49 | 4.19 | 4.22 | 297,825 |
| 04/11/26 | 4.29 | 4.495 | 4.2401 | 4.46 | 268,893 |
| 03/11/26 | 4.14 | 4.33 | 4.105 | 4.17 | 391,257 |
| 02/11/26 | 4.15 | 4.29 | 3.945 | 4.10 | 330,293 |
|
|
||||
|
|
||||
|
|